Tesofensine is a small molecule drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications. The directory classifies it as a under development API with a synthetic source/manufacturing origin. Other names for this substance include Tesomet and Saniona. Its PubChem CID is 11370864.
Tesofensine
| CAS No | 195875-84-4 |
|---|---|
| Molecular Formula | C17H23Cl2NO |
| Molecular Weight | 328.3 g/mol |
| Synonyms | (1R,2R,3S,5S)-3-(3,4-dichlorophenyl)-2-(ethoxymethyl)-8-methyl-8-azabicyclo[3.2.1]octane |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Tesofensine is a small molecule drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications. The directory classifies it as a under development API with a synthetic source/manufacturing origin.
The listed CAS number is 195875-84-4.
The listed molecular formula is C17H23Cl2NO.
The listed molecular weight is 328.3 g/mol.
(1R,2R,3S,5S)-3-(3,4-dichlorophenyl)-2-(ethoxymethyl)-8-methyl-8-azabicyclo[3.2.1]octane.
The source lists Tesomet and Saniona.